Patriot Financial Group Insurance Agency’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-212
Closed -$13K 1818
2022
Q2
$13K Buy
212
+52
+33% +$4.27K ﹤0.01% 1163
2022
Q1
$19K Sell
160
-124
-44% -$14.5K ﹤0.01% 1116
2021
Q4
$43K Buy
284
+42
+17% +$5.67K 0.01% 937
2021
Q3
$29K Hold
242
0.01% 1068
2021
Q2
$24K Buy
242
+42
+21% +$3.75K ﹤0.01% 1110
2021
Q1
$18K Buy
200
+100
+100% +$9.29K ﹤0.01% 1150
2020
Q4
$10K Hold
100
﹤0.01% 1236
2020
Q3
$11K Hold
100
﹤0.01% 1016
2020
Q2
$10K Hold
100
﹤0.01% 986
2020
Q1
$6K Hold
100
﹤0.01% 1034
2019
Q4
$6K Hold
100
﹤0.01% 953
2019
Q3
$6K Hold
100
﹤0.01% 907
2019
Q2
$6K Hold
100
﹤0.01% 913
2019
Q1
$6K Buy
+100
New +$5.25K ﹤0.01% 820

Other funds holding TNDM

Patriot Financial Group Insurance Agency's TNDM Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of Tandem Diabetes Care (TNDM) in Q3 2022, closing a stake of 212 shares — an estimated $13K sold.

Patriot Financial Group Insurance Agency first reported a position in TNDM in Q1 2019 and held it in 14 quarters. The position peaked at $43K in Q4 2021. 299 funds tracked by Wall St. Rank hold TNDM as of Q3 2022.

  • Patriot Financial Group Insurance Agency reported no remaining Tandem Diabetes Care position as of Q3 2022 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 212 Tandem Diabetes Care shares in Q3 2022, an estimated $13K.
  • Patriot Financial Group Insurance Agency first reported a position in Tandem Diabetes Care in Q1 2019 and held it in 14 quarters.
  • Patriot Financial Group Insurance Agency's Tandem Diabetes Care position peaked at $43K in Q4 2021.
  • 299 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.